Status:
RECRUITING
Rectosigmoid Resection vs Seromuscular Tumor Shaving in Ovarian Cancer Surgery
Lead Sponsor:
Cukurova University
Conditions:
Epithelial Ovarian Cancer
Rectosigmoid Cancer Metastatic
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Ovarian cancer is the most common cause of death in gynecological cancer. Approximately 75% of epithelial ovarian cancers are detected at an advanced stage. Metastasis and spread are mostly through tr...
Eligibility Criteria
Inclusion
- Epithelial ovarian cancer
- Negative colonoscopy ( no mucosal involvement)
- Intraoperative confirmed serosal or seromuscular rectosigmoid infiltration
- ECOG \<3
- ASA \<3
Exclusion
- Nonepithelial ovarian cancers
- Rectosigmoid mucosal infiltration
- Total or subtotal colectomy necessitating large bowel infiltrations
- ECOG \>2
- ASA \>2
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04665635
Start Date
March 1 2021
End Date
December 1 2026
Last Update
August 29 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Cukurova University
Adana, Turkey (Türkiye), 01330
2
Cukurova University
Adana, Turkey (Türkiye), 01330